Skip to main content Deutsch

News

CCCD Starter Grant Call 2025

Das CCCD freut sich, den Start des Bewerbungsverfahrens für zwei CCCD-Starter Grants 2025 bekannt zu geben! Dieser Förderpreis richtet sich an…

AI improves evaluation of lung function tests in ILD

Medicine & Science

A study conducted by a research team led by Daniela Gompelmann from MedUni Vienna shows that AI improves the detection of interstitial lung disease…

Clemens Aigner on the ESTS Board of Directors

People of the MedUni Vienna

Clemens Aigner, Head of the Department of Thoracic Surgery and Head of the CCCD (Medical University of Vienna), was appointed to the Board of…

Importance of PAH centers for early detection and treatment

Medicine & Science

In this interview, Nika Skoro-Sajer from MedUni Vienna talks about the role of pulmonary arterial hypertension (PAH) centers in the early detection…

Study on E-Cigarettes and Lung Inflammation

A study shows that e-cigarettes with nicotine increase pneumonia markers in the blood. Lukas Antoniewicz from MedUni Vienna and co-author of the study…

Important step towards improving diagnosis and treatment of brain metastases

Medicine & Science

Brain metastases often occur as a result of advanced cancer and, despite medical innovations, are still associated with a poor prognosis. Now, an…

Asthma and Allergies in Austria

Medicine & Science

On the occasion of World Asthma Day, Marco Idzko from MedUni Vienna comments on the increase in asthma and allergy cases in Austria by 2050. He…

Lung Cancer Screening and Incidental Findings

Medicine & Science

Daniela Gompelmann from MedUni Vienna refers to the frequent incidental pulmonary findings in lung cancer screening, including emphysema and…

Cystic fibrosis: increased life expectancy

Medicine & Science

At an online training event, Saskia Gruber from MedUni Vienna spoke about the considerable progress made in the treatment of cystic fibrosis. Dieter…

Horizon program "LifeLUNG"

Medicine & Science

As part of the Horizon Program, the EU is funding the LifeLUNG program for the genetic modification of donor lungs with a total volume of € 4.2…